(Q44027980)

English

Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy (English)

1 reference

Europe PubMed Central

29 November 2017

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Krystal L Edwards

1

1 reference

Europe PubMed Central

29 November 2017

Daniel M Riche

2

1 reference

Europe PubMed Central

29 November 2017

Jeffrey S Stroup

3

1 reference

Europe PubMed Central

29 November 2017

Jennifer D Goldman-Levine

4

1 reference

Europe PubMed Central

29 November 2017

Rosalyn S Padiyara

5

1 reference

Europe PubMed Central

29 November 2017

L Brian Cross

6

1 reference

Europe PubMed Central

29 November 2017

Michael P Kane

7

1 reference

Europe PubMed Central

29 November 2017

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

29 November 2017

Pharmacotherapy

1 reference

Europe PubMed Central

29 November 2017

30

1 reference

Europe PubMed Central

29 November 2017

955-965

1 reference

Europe PubMed Central

29 November 2017

9

1 reference

Europe PubMed Central

29 November 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The relation of type 2 diabetes and cancer

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Cancer as an endocrine problem

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Diabetes mellitus and risk of breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Diabetes mellitus and risk of bladder cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Colorectal cancer: another complication of diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

A case-control study of diabetes mellitus and cancer risk

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The IGF-I receptor in cancer research

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The role of the IGF system in cancer: from basic to clinical studies and clinical applications

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Growth effects of insulin and insulin analogues

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin glargine and malignancy: an unwarranted alarm

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin glulisine--a comprehensive preclinical evaluation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Gastric cancer in very young adults: apropos four patients and a review of the literature

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

A 5' Leader of Rbm3, a Cold Stress-induced mRNA, Mediates Internal Initiation of Translation with Increased Efficiency under Conditions of Mild Hypothermia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Hormone responsive human breast cancer in long-term tissue culture: effect of insulin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The IGF system and breast cancer

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin-like growth factor 1 (IGF-1): a growth hormone

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Novel insulin analogues and its mitogenic potential

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.9.955

21 January 2018

Identifiers

10.1592/PHCO.30.9.955

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44027980&oldid=2105767776"